rs397515742
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_000116.5(TAFAZZIN):c.371-13C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000954 in 1,048,184 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000116.5 intron
Scores
Clinical Significance
Conservation
Publications
- Barth syndromeInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000116.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAFAZZIN | TSL:1 MANE Select | c.371-13C>G | intron | N/A | ENSP00000469981.1 | Q16635-1 | |||
| TAFAZZIN | TSL:1 | c.424+521C>G | intron | N/A | ENSP00000419854.3 | A0A499FJ53 | |||
| TAFAZZIN | TSL:1 | c.295+521C>G | intron | N/A | ENSP00000358791.4 | F6Y2X3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.54e-7 AC: 1AN: 1048184Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 324440 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 23
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at